Making c4+ products in bacteria
US-2015376658-A1 · Dec 31, 2015 · US
US10941419B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10941419-B2 |
| Application number | US-201615547563-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 3, 2016 |
| Priority date | Feb 3, 2015 |
| Publication date | Mar 9, 2021 |
| Grant date | Mar 9, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to the production of aromatic hexanols and compositions containing them. In particular provided herein are methods of producing hexenols comprising: a) contacting a hydroperoxide of a polyunsaturated fatty acid with a modified hydroperoxide lyase to form a hexenal; and b) reducing the hexenal to a hexenol in the presence of a hydride donor, a ketoreductase, and a co-factor wherein the contacting and reducing steps are carried out at essentially the same time in the substantial absence of baker's yeast.
Opening claim text (preview).
What is claimed is: 1. A method of producing an alcohol comprising: a) contacting a 9- or 13-hydroperoxide of a polyunsaturated fatty acid selected from linoleic acid and alpha linolenic acid with the respective hydroperoxide lyase to form an aldehyde; and b) reducing the aldehyde to form the alcohol in the presence of a hydride donor, a ketoreductase, and a co-factor wherein the contacting and reducing steps are carried out concomitantly: wherein the hydride donor is selected from the group consisting of a secondary alcohol, a primary alcohol, an alkandiol and a hydroxy acid or one of its esters; the cofactor is selected from NADH and NADPH; the hydroperoxide lyase is stable in the presence of the hydride donor, thus allowing for the concomitant hydroperoxide cleavage and aldehyde reduction; and the method is performed in the absence of intact cells. 2. The method as recited in claim 1 comprising a) contacting a 13-hydroperoxide of the polyunsaturated fatty acid with a 13-hydroperoxide lyase to form a hexenal; and b) reducing the hexenal in the presence of the hydride donor, the ketoreductase, and the co-factor. 3. The method as recited in claim 1 comprising a) contacting a 13-hydroperoxide of a polyunsaturated fatty acid with a 13-hydroperoxide lyase to form n-hexanal; and b) reducing the hexanal in the presence of the hydride donor, the ketoreductase, and the co-factor. 4. The method as recited in claim 2 wherein the hexenal is (Z)-3-hexenal, the method further comprising reducing the (Z)-3-hexenal to (Z)-3-hexenol in the presence of a secondary alcohol, the ketoreductase, and the co-factor. 5. The method as recited in claim 1 comprising a) contacting a 9-hydroperoxide of the polyunsaturated fatty acid with a 9-hydroperoxide lyase to form an aldehyde selected from the group consisting of a nonenal and nonadienal; and b) reducing the aldehyde in the presence of the hydride donor, the ketoreductase, and the co-factor. 6. The method as recited in claim 1 wherein the aldehyde is selected from the group consisting of (Z)-3-nonenal and (Z,Z)-3,6-nonadienal, the method further comprising reducing the aldehyde in the presence of the hydride donor, the ketoreductase, and the cofactor. 7. The method as recited in claim 1 wherein the contacting and reducing steps are carried out in the absence of baker's yeast. 8. The method as recited claim 1 , wherein: the secondary alcohol is selected from the group consisting of isopropanol, isoamyl alcohol, glycerol, isobutanol, butan-2-ol, propylene glycol, fenchol, borneol, menthol, carveol, methyl-p-tolyl-carbinol, 8-cymenol, oct-1-en-3-ol, pentan-2-ol, pentan-3-ol, 4-methyl-2-pentanol, hexan-2-ol, heptan-2-ol, octan-2-ol, nonan-2-ol, decan-2-ol, and undecan-2-ol; the alkandiol is selected from the group consisting of butan-1,4-diol, butan-2,3-diol and ethylene glycol; and the hydroxy acid ester is selected from the group consisting of calcium lactate, ethyl lactate, propyl lactate and butyl lactate.
Cytochrome-b5 reductase (1.6.2.2) · CPC title
Lyases (4.) · CPC title
containing oxygen as the only heteroatom · CPC title
acyclic · CPC title
Reduction in general · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.